Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.®TB and QFT-GIT)

6Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Background: The standardized blood-based TB antigen-specific T cell assay, T-SPOT.®TB, is ~10% more sensitive than QuantiFERON®-TB-GIT (QFT-GIT) in detecting presumed latent TB infection (LTBI). Whilst T-SPOT.®TB uses a fixed number of lymphocytes per well, QFT-GIT uses a fixed volume of blood (~1 mL). However, the person-to-person lymphocyte count can vary by 2 to 3 fold. We hypothesized that this variability could explain the reduced sensitivity of QFT-GIT. The findings could have potential implications for improving case detection. Methods: T-SPOT.®TB was compared to QFT-GIT readouts before and after normalization of lymphocyte count (by adjusting the blood volume or lymphocyte enrichment within a fixed 1 mL volume) to an arbitrary value of 2.5×106 cells/mL. Within-test variability was evaluated to meaningfully interpret results. Results: In patient-specific optimization experiments IFN-γ concentrations significantly increased when QFTGIT positive samples were enriched with increasing concentrations of lymphocytes (1×106 vs. 2.5×106 cells/mL). However, for the group as a whole lymphocyte enrichment whilst maintaining a ~1 mL volume, compared to un-enriched samples, did not significantly increase IFN-γ [median (range): 0.03 (0-4.41) vs. 0.20 (0-2.40) IU/mL; P=0.64]. There was also no increase in IFN-γ readouts when QFT-GIT lymphocyte numbers were corrected (to 2.5×106 lymphocytes/mL) using volume adjustment. Interestingly, adjusted values were significantly lower than unadjusted ones [median (range): 0.02 (0-12.93) vs. 0.09 (0-14.23) IU/mL; P=0.008]. Conclusions: In QFT-GIT negative subjects lymphocyte enrichment did not increase QFT-GIT positivity rates. The reduced clinical sensitivity of the QFT-GIT assay, compared to T-SPOT.®TB, is likely to be due to factors other than lymphocyte count alone. Further studies are required to clarify these findings.

Cite

CITATION STYLE

APA

van Zyl-Smit, R. N., Lehloenya, R. J., Meldau, R., & Dheda, K. (2016). Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.®TB and QFT-GIT). Journal of Thoracic Disease, 8(3), 482–489. https://doi.org/10.21037/jtd.2016.02.65

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free